Member Area

Farmavita.Net - Pharmaceutical Licensing Network

Tuesday
Sep 16th
Repaglinide Print E-mail
There is on-going development of  generic  EU CTD Dossier of Repaglinide, tablets, 0.5/1/2 mg.

Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with Bolar-provisions. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights.

Repaglinide belongs to the meglitinide class of blood glucose-lowering drugs.

Repaglinide lowers blood glucose by stimulating the release of insulin from the pancreas. It achieves this by closing ATP-dependent potassium channels in the membrane of the beta cells. This depolarizes the beta cells, opening the cells' calcium channels, and the resulting calcium influx induces insulin secretion.

More details at: http://www.rxlist.com/prandin-drug.htm.

Comments
Search RSS
Tanvir Halim  - rapaglinide   |2012-09-01 09:19:57
Is your formulation identical to a reference product and does it
pass
comparative dissolution ?
Only registered users can write comments!

3.26 Copyright (C) 2008 Compojoom.com / Copyright (C) 2007 Alain Georgette / Copyright (C) 2006 Frantisek Hliva. All rights reserved."

Read also at Pharmaceutical Licensing Network
Related News
Newer news items
Related Items
Farmavita.Net - The Pharmaceutical Licensing Network
 
< Prev   Next >
Advertisement
 

Featured Partners

 
meddevma14_150x150.gif
bals_150x150_anim.gif 
150-150payers.jpg  
pharmaccess14b_150x150.gif 
medaff14b_150x150.gif
bals150_150x150.gif 
150x150copd.jpg 
2014-pmr-eur-banner-150x150.gif  
2015-pmr-banner-150x150.gif 
medcommeu15_150x150.gif 

Login to Farmavita.Net

membership is FREE

Follow us on:




Join our LinkedIn Group

BabelFish Translator




Click Flag for Translation

Who's Online

We have 233 guests online

Farmavita.Net RSS News


Reports

rbdl0002_innovations-in-inj.gif 

Events

pc_150x150.gif

Reports

rbhc0264_privatehealthcare.gif 

REPORTS

farmavita_research-store.gif